Thursday, March 30, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Anthrax Guidance for First Responders

by Global Biodefense Staff
October 18, 2012

The Department of Homeland Security (DHS) has issued guidance developed by a federal interagency working group to educate first responders on protective actions they should take in the event of a wide-area anthrax release.

The guidance focuses on a large-scale Bacillus anthracis (B. anthracis) aerosol attack in a major U.S. city and for minimizing the amount of exposure in the first week of a response. Information is provided on pre- and post-event vaccination, personal protective equipment, and decontamination recommendations.

The Guidance for Protecting Responders’ Health during the First Week Following a Wide-Area Aerosol Anthrax Attack (.pdf) is expected to evolve over time based on the understanding of risks, stakeholder feedback, scientific developments, and new environmental monitoring techniques.

First responders play a critical role in ensuring a rapid distribution of post-exposure prophylaxis to reduce the risk of fatality associated with inhalation anthrax.

Current recommendations for post-exposure prophylaxis for the general population include timely administration of a minimum 60-day course of oral antimicrobial drugs (e.g., doxycycline or ciprofloxacin) following potential or imminent  exposure to  B. anthracis spores in combination with  three doses of  anthrax vaccine adsorbed  (AVA, BioThrax™), given subcutaneously at 0, 2, and 4 weeks for those not previously vaccinated.

 

Tags: AnthraxAntimicrobialsBioterrorismDHSMobile Response

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC